4 / 9
Volume 7, Issue 6 (Suppl)
J Gastrointest Dig Syst, an open access journal
ISSN: 2161-069X
Page 20
Notes:
December 07-08, 2017 Madrid, Spain
&
13
th
International Conference on Clinical Gastroenterology & Hepatology
2
nd
International Conference on Digestive Diseases
CO-ORGANIZED EVENT
Inflammatory bowel disease and pregnancy: Management and up-to date guidelines
I
nflammatory bowel diseases (IBD) affect mainly young people who may have pregnancy will. Despite many studies and
recommendations, patients and gastroenterologists still have bias ideas regarding risks and consequences of pregnancy in
IBD patients. This may lead to voluntary infertility or bad observance, whereas a controlled disease and maintenance therapy
are key points to minimize the risk of maternal or fetal complications. Except for methotrexate, most IBD medications do not
have any side effects on the offspring. Disease flare has to be treated properly without delay and corticosteroids should be the
first treatment to propose. Surgery should not be delayed if needed. Patient education and information should be promoted
before and during all pregnancy. Here we present a review of the last studies regarding management of pregnancy in IBD
according to the last European guidelines.
Biography
Triki Ismail is a Gastroenterologist and specialist in the management of IBD has his hospital and liberal experience to treat inflammatory bowel disease in all of these
aspects. As he has done research work in this direction and he is also Member of several associations for patients.
triki.ismail@yahoo.comTriki Ismail
University of Oran, Algeria
Triki Ismail, J Gastrointest Dig Syst 2017, 7:6(Suppl)
DOI: 10.4172/2161-069X-C1-057